JASON ROBERT WESTIN to Cell Line, Tumor
This is a "connection" page, showing publications JASON ROBERT WESTIN has written about Cell Line, Tumor.
Connection Strength
0.108
-
Degradation trumps mutations in cancer. Science. 2024 Feb 02; 383(6682):480-481.
Score: 0.081
-
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas. Clin Cancer Res. 2018 08 15; 24(16):3967-3980.
Score: 0.014
-
Tonic B-cell receptor signaling in diffuse large B-cell lymphoma. Blood. 2017 08 24; 130(8):995-1006.
Score: 0.013